AR	Androgen Receptor
PCa	Prostate cancer
Cyp19a1	Aromatase
TAD	Tadalafil
LnCAP	Androgen-sensitive human PCa cell line
BCT	Bicalutamide
T	Testosterone
DHT	Dihydrotestosterone
AREs	Androgenr esponse elements
ADT	Androgen deprivation therapy
CRPC	Castration-resistant prostate cancer
cAMP	Cyclic adenosine monophosphate
cGMP	Cyclic guanosine monophosphate
PDE	Phosphodiesterase
PDE5i	PDE5 inhibitor
CHX	Cycloheximide
PSA	Prostatic specific antigen
MDV	MDV3100
CYT	Cytoplasmic fraction
NUC	Nuclear fraction
RD	Human Rhabdomyosarcoma Cell Lines
ED	Erectile dysfunction
BDH	Benign prostatic hyperplasia
ERβ	Estrogen receptor beta
LUTS	Lower urinary tract symptoms
PSA	Prostatic specific antigen
PD-1	Programmed cell death protein 1
PD-1L	Programmed death-ligand 1
AIs	Aromatase inhibitors
ERα	Estrogen receptor alpha
ERβ	Estrogen receptor beta
HGPIN	High grade prostatic intraepithelial neoplasia